In reading over the review of melatonin, this paragraph particularly struck me.
Melatonin has a protective effect on the cholinergic system. It prevents the peroxynitrite-induced
inhibition of choline transport and ChAT activity in synaptosomes and synaptic vesicles [126].
Melatonin treatment of eight-month-old APP695 transgenic mice significantly improved the profound
reduction in ChAT activity in the frontal cortex and the hippocampus [81]. Melatonin also antagonizes
the spatial memory deficit and the decreased ChAT activity found in adult ovariectomized rats [127].
However, in rats perfused intracerebroventricularly with Aβ for 14 days, melatonin was unable to
restore ChAT activity [128]. Melatonin inhibited lipopolysaccharide- and streptozotocin-induced
increase in AChE activity [129]. Recently hybrids of the AChE inhibitor tacrine and melatonin were
synthesized as new drug candidates for treating AD [130,131]. These hybrids showed better
antioxidant and cholinergic-preserving activity than tacrine or melatonin alone. The direct intracerebral
administration of one of these hybrids decreased induced cell death and Aβ load in the APP/PS1
mouse brain parenchyma accompanied by a recovery of cognitive function [131].
My thinking is that many of these compounds (such as melatonin, ferulic acid, and curcumin, for instance)/drugs (pbt2, for instance) show efficacy in certain areas in mice and in human beings, but when applied to humans they seem to fall just a bit short when it comes to cognitive function. There may be great potential for hybrids, natural compounds containing multiple antioxidants, and/or compounds that are highly concentrated and can be inhaled almost directly into the brain (various essential oils via aromatherapy) to get you over that last hump.
- Forums
- ASX - By Stock
- ATH
- I don't know! Maybe...
ATH
alterity therapeutics limited
Add to My Watchlist
6.67%
!
1.4¢

I don't know! Maybe..., page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $128.9M |
Open | High | Low | Value | Volume |
1.4¢ | 1.5¢ | 1.4¢ | $250.3K | 17.87M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 838549 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 24790821 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 838549 | 0.014 |
33 | 20499472 | 0.013 |
35 | 15994423 | 0.012 |
21 | 15097532 | 0.011 |
35 | 18299059 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 24790821 | 19 |
0.016 | 4996642 | 12 |
0.017 | 8679558 | 11 |
0.018 | 12254020 | 24 |
0.019 | 15047176 | 11 |
Last trade - 13.40pm 30/07/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |